This archive contains the following articles listed by volume, issue and page number:
 |
|
|
HRT RELATED ARTICLES |
Title (Click for Details) |
Vol/Issue |
Page |
PreScription: The NASEM cBHT Report, Part 1 |
Vol. 24 No. 6 |
444 |
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 |
Vol. 24 No. 6 |
466 |
Calculations |
Vol. 24 No. 2 |
128 |
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules |
Vol. 24 No. 1 |
62 |
Calculations |
Vol. 23 No. 6 |
484 |
Calculations |
Vol. 23 No. 4 |
312 |
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches |
Vol. 23 No. 4 |
340 |
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets |
Vol. 23 No. 1 |
62 |
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy |
Vol. 23 No. 1 |
77 |
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) |
Vol. 22 No. 6 |
504 |
Establishing a Rationale for Compounding Hormone Replacement Therapy |
Vol. 22 No. 3 |
190 |
Trace Level Analysis of Airborne Hormone Particulates |
Vol. 22 No. 3 |
257 |
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement |
Vol. 21 No. 6 |
444 |
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives |
Vol. 21 No. 6 |
530 |
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases |
Vol. 21 No. 3 |
238 |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 |
Vol. 21 No. 1 |
6 |
Basics of Compounding with Dilutions and Concentrates |
Vol. 21 No. 1 |
39 |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 |
Vol. 20 No. 6 |
447 |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 |
Vol. 20 No. 5 |
359 |
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base |
Vol. 20 No. 5 |
407 |
Progesterone 10% Cream |
Vol. 20 No. 5 |
412 |
Calculations |
Vol. 20 No. 4 |
316 |
Estradiol Valerate 40-mg/mL in Oil Injection |
Vol. 19 No. 6 |
509 |
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity |
Vol. 19 No. 4 |
289 |
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy |
Vol. 19 No. 3 |
195 |
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review |
Vol. 19 No. 1 |
6 |
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations |
Vol. 18 No. 6 |
512 |
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream |
Vol. 18 No. 4 |
332 |
Testosterone Enanthate 200-mg/mL Injection |
Vol. 18 No. 2 |
151 |
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding |
Vol. 18 No. 2 |
162 |
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study |
Vol. 18 No. 1 |
70 |
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy |
Vol. 17 No. 6 |
452 |
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules |
Vol. 17 No. 3 |
230 |
Treatment Options for Male Hypogonadism |
Vol. 17 No. 1 |
28 |
Testosterone Cypionate 100-mg/mL Injection |
Vol. 17 No. 1 |
73 |
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women |
Vol. 17 No. 1 |
74 |
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol |
Vol. 16 No. 5 |
376 |
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy |
Vol. 16 No. 2 |
110 |
Transdermals: The Skin as Part of a Drug Delivery System |
Vol. 15 No. 4 |
308 |
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review |
Vol. 15 No. 4 |
290 |
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women |
Vol. 14 No. 6 |
465 |
Bioidentical Hormones in the News |
Vol. 14 No. 5 |
374 |
The Role of Sex Hormones on Fibromyalgia Pain Mediators |
Vol. 14 No. 3 |
193 |
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject |
Vol. 14 No. 2 |
100 |
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study |
Vol. 14 No. 2 |
165 |
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing |
Vol. 13 No. 5 |
392 |
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding |
Vol. 13 No. 4 |
314 |
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison |
Vol. 13 No. 4 |
342 |
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia |
Vol. 13 No. 4 |
345 |
The Physiologic Role and Use of Estriol |
Vol. 13 No. 4 |
270 |
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation |
Vol. 13 No. 4 |
280 |
Estradiol 0.1% Vaginal Solution |
Vol. 12 No. 5 |
450 |
PreScription: First Estriol, Then What? |
Vol. 12 No. 4 |
284 |
PostScription: It Is Not Just What You Say…But How You Say It! |
Vol. 12 No. 4 |
375 |
Estriol: Women's Choice vs. A Manufacturer's Greed |
Vol. 12 No. 4 |
286 |
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women |
Vol. 12 No. 4 |
295 |
Progesterone and Traumatic Brain Injury: A Review of Literature |
Vol. 12 No. 4 |
310 |
Marketing for Your Community |
Vol. 12 No. 4 |
338 |
Calculations |
Vol. 12 No. 4 |
354 |
Hormone Therapy: It's Time for a Second Opinion |
Vol. 12 No. 2 |
122 |
PreScription: Bias, NAMS, and HRT |
Vol. 11 No. 4 |
266 |
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature |
Vol. 11 No. 4 |
269 |
The History of Progesterone |
Vol. 11 No. 4 |
274 |
Premarin: The Intriguing History of a Controversial Drug |
Vol. 11 No. 4 |
282 |
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement |
Vol. 11 No. 4 |
288 |
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones |
Vol. 11 No. 4 |
292 |
The Politics of Hormone Replacement Therapy |
Vol. 11 No. 4 |
278 |
Case Report: Treatment of Labial Adhesions in a Child |
Vol. 11 No. 1 |
27 |
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Vol. 10 No. 3 |
175 |
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update |
Vol. 10 No. 3 |
187 |
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women |
Vol. 9 No. 4 |
252 |
Book Reviews: Perfect Balance |
Vol. 9 No. 4 |
253 |
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome |
Vol. 9 No. 4 |
259 |
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy |
Vol. 9 No. 4 |
266 |
Natural Progesterone Handout |
Vol. 9 No. 4 |
281 |
PostScription: Women in Balance: A Cause Worth Advancing |
Vol. 9 No. 4 |
327 |
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY |
Vol. 9 No. 1 |
5 |
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle |
Vol. 8 No. 6 |
412 |
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? |
Vol. 8 No. 6 |
419 |
The Salivary Hormone Profile in the Clinical Evaluation of Women |
Vol. 8 No. 6 |
427 |
Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
Estradiol 0.01% Wound Gel |
Vol. 8 No. 4 |
297 |
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy |
Vol. 8 No. 4 |
313 |
Andropause: New Perspectives |
Vol. 8 No. 3 |
175 |
Estrogen 0.625-mg/5-g Vaginal Gel |
Vol. 8 No. 3 |
185 |
Testosterone Propionate 100-mg/mL in Oil Injection |
Vol. 8 No. 3 |
222 |
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 |
Vol. 8 No. 2 |
96 |
Women's Oral Health: Is There a Hormonal Link? |
Vol. 8 No. 1 |
10 |
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 |
Vol. 8 No. 1 |
16 |
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations |
Vol. 7 No. 6 |
490 |
Book and Literature Reviews |
Vol. 7 No. 5 |
324 |
Patient Handout - Hormone Replacement Therapy |
Vol. 7 No. 5 |
339 |
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 |
Vol. 7 No. 5 |
330 |
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 |
Vol. 7 No. 4 |
250 |
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT |
Vol. 7 No. 4 |
258 |
Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection |
Vol. 7 No. 4 |
299 |
Sildenafil 25-mg Troches |
Vol. 7 No. 3 |
171 |
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection |
Vol. 7 No. 3 |
171 |
Panel Discussion: Prohormones |
Vol. 7 No. 2 |
94 |
Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD. |
Vol. 7 No. 1 |
24 |
Andropause: A Review of Treatment Options |
Vol. 6 No. 6 |
458 |
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy |
Vol. 6 No. 5 |
377 |
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix |
Vol. 6 No. 5 |
378 |
A Review of Current Research on the Effects of Progesterone |
Vol. 6 No. 4 |
245 |
The Hormonal Link to Breast Cancer: The Estrogen Matrix |
Vol. 6 No. 4 |
250 |
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women |
Vol. 6 No. 4 |
255 |
Establishing an Andropause Practice |
Vol. 6 No. 4 |
259 |
Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel |
Vol. 6 No. 4 |
293 |
Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops |
Vol. 6 No. 4 |
294 |
Estradiol 0.5-mg Sublingual Troches |
Vol. 6 No. 4 |
295 |
Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel |
Vol. 6 No. 4 |
296 |
Estradiol 1-mg/0.1-g Topical Cream |
Vol. 6 No. 4 |
297 |
Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution |
Vol. 6 No. 4 |
298 |
Estriol 2-mg/mL Topical Gel |
Vol. 6 No. 4 |
299 |
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops |
Vol. 6 No. 4 |
300 |
Testosterone 25-mg in Oil Capsules |
Vol. 6 No. 4 |
301 |
Testosterone 50-mg/mL Topical Gel |
Vol. 6 No. 4 |
302 |
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease |
Vol. 6 No. 3 |
171 |
Tranilast 0.8% for Iontophoresis |
Vol. 6 No. 2 |
133 |
Tranilast Topical 2% Penetrating Mixture |
Vol. 6 No. 2 |
134 |
Bioidentical Hormone Replacement Therapy, Part 3, A Review of |
Vol. 6 No. 2 |
142 |
Bioidentical Hormone Replacement Therapy, Part 2, A Review of |
Vol. 6 No. 1 |
50 |
Hormone Replacement Therapy, Part 2: Estrogen Defined |
Vol. 5 No. 6 |
460 |
The Science Behind Hormone Replacement Therapy, Part 1 |
Vol. 5 No. 6 |
462 |
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want |
Vol. 5 No. 5 |
332 |
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment |
Vol. 5 No. 5 |
336 |
Bioidentical Hormones in the Treatment of Osteoporosis |
Vol. 5 No. 5 |
339 |
The Value of Hormone Assessment |
Vol. 5 No. 5 |
342 |
Estrogen Replacement: A Review of Current Literature |
Vol. 5 No. 5 |
346 |
Treating Andropause: Prohormones and Hormone Metabolic Modifiers |
Vol. 5 No. 5 |
351 |
Bioidentical Topical Progesterone: A Survey of Patients |
Vol. 5 No. 5 |
354 |
Book Reviews: Hormone Replacement Therapy |
Vol. 5 No. 5 |
356 |
Compounding in History: Treatment at the Change of Life |
Vol. 5 No. 5 |
365 |
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO) |
Vol. 5 No. 5 |
374 |
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream |
Vol. 5 No. 5 |
375 |
Libido Cream |
Vol. 5 No. 5 |
376 |
Progesterone 50-mg/mL Clear Topical Solution |
Vol. 5 No. 5 |
377 |
Progesterone Low-Potency 0.0065% Topical Cream |
Vol. 5 No. 5 |
378 |
Sildenafil 1% Topical Cream |
Vol. 5 No. 5 |
379 |
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO) |
Vol. 5 No. 5 |
380 |
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches |
Vol. 5 No. 5 |
381 |
Testosterone 25-mg/mL Clear Solution |
Vol. 5 No. 5 |
382 |
Testosterone 2% Scalp Lotion |
Vol. 5 No. 5 |
383 |
Flush Powder, No. 2 |
Vol. 5 No. 5 |
366 |
Tincture of Black Cohosh |
Vol. 5 No. 5 |
366 |
Lydia Pinkham's Vegetable Compound |
Vol. 5 No. 5 |
366 |
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of |
Vol. 5 No. 3 |
218 |
Infertility Care and the Role of the Compounding Pharmacist |
Vol. 5 No. 2 |
136 |
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 |
Vol. 5 No. 1 |
52 |
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach |
Vol. 4 No .6 |
414 |
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1 |
Vol. 4 No .6 |
421 |
Book Reviews: Women's Health |
Vol. 4 No .6 |
424 |
Hormone Replacement Therapy: Selected Recent References |
Vol. 4 No .6 |
426 |
Testosterone Deficiency in Men: New Treatments for Andropause |
Vol. 4 No .6 |
429 |
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists |
Vol. 4 No .6 |
432 |
Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules |
Vol. 4 No .6 |
458 |
Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules |
Vol. 4 No .6 |
459 |
Estrogen 0.625-mg/5-g Vaginal Gel |
Vol. 4 No .6 |
460 |
Progesterone Cycle Pack 35/50/75/100-mg Capsules |
Vol. 4 No .6 |
461 |
Testosterone 1-mg/0.1-mL Nasal Spray |
Vol. 4 No .6 |
462 |
Testosterone 1-mg/0.1-mL in a PLO Gel |
Vol. 4 No .6 |
463 |
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray |
Vol. 4 No .6 |
464 |
Triple Estrogen 2.5-mg/0.1-mL PLO |
Vol. 4 No .6 |
465 |
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops |
Vol. 4 No .6 |
466 |
Triple Estrogen 2.5-mg Tablet Triturates |
Vol. 4 No .6 |
467 |
Estrogen Use in Dogs: Indications and Complications |
Vol. 4 No .6 |
468 |
Natural Estrogens: A Review of the Primary Literature |
Vol. 4 No. 2 |
110 |
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops |
Vol. 3 No. 6 |
461 |
Linguet Base (Soft Lozenge) |
Vol. 3 No. 6 |
462 |
Sorbitol Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
Sucrose Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
Polyethylene Glycol (PEG) Troches (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
Chewable Lozenges |
Vol. 3 No. 6 |
464 |
Interview: Katharina Dalton, MD: Progesterone and Related Topics |
Vol. 3 No. 5 |
332 |
Top Ten HRT Compound Preparations |
Vol. 3 No. 5 |
342 |
Wilson's Syndrome and T3 Therapy |
Vol. 3 No. 5 |
344 |
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS |
Vol. 3 No. 5 |
352 |
Andropause: Annotated Citations from the Literature |
Vol. 3 No. 5 |
355 |
Women's Health Book Reviews |
Vol. 3 No. 5 |
357 |
Planning and Marketing a Natural HRT Patient Seminar |
Vol. 3 No. 5 |
360 |
Lubricating Jelly Formula |
Vol. 3 No. 5 |
388 |
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
392 |
Ethinyl Estradiol 0.2-mg Gelatin Troches |
Vol. 3 No. 5 |
393 |
Progesterone 50-mg/mL Topical Gel |
Vol. 3 No. 5 |
394 |
Progesterone 100-mg/mL Sublingual Drops |
Vol. 3 No. 5 |
395 |
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules |
Vol. 3 No. 5 |
396 |
Progesterone 10% Topical Cream |
Vol. 3 No. 5 |
397 |
Progesterone 200-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
398 |
Testosterone 1-mg Buccal Troches |
Vol. 3 No. 5 |
399 |
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules |
Vol. 3 No. 5 |
400 |
Triple Estrogen 2.5-mg Slow-Release Capsules |
Vol. 3 No. 5 |
401 |
Estradiol 5-mg/mL-in-Oil Injection |
Vol. 3 No. 4 |
300 |
Tri-Est 2.5-mg/mL Aqueous Injection |
Vol. 3 No. 4 |
304 |
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography |
Vol. 3 No. 4 |
314 |
Progesterone 100-mg/mL Veterinary Injection |
Vol. 3 No. 3 |
223 |
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography |
Vol. 3 No. 3 |
239 |
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis |
Vol. 3 No. 2 |
76 |
Male Impotency and the Compounding Pharmacist |
Vol. 3 No. 2 |
80 |
Medication Combinations for Penile Injections |
Vol. 3 No. 2 |
81 |
Natural Testosterone: Hormone of the Heart |
Vol. 3 No. 2 |
88 |
Case Report: Testosterone Supplementation in a Vasectomy Patient |
Vol. 3 No. 2 |
101 |
Natural HRT: Corrective Measures When the System Goes Down |
Vol. 3 No. 2 |
109 |
Dehydroepiandrosterone 50-mg Capsules |
Vol. 3 No. 2 |
131 |
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection |
Vol. 3 No. 2 |
134 |
Sildenafil Citrate 25-mg Sublingual Troches |
Vol. 3 No. 2 |
135 |
Testosterone-Menthol Eutectic Ointment (2% Testosterone) |
Vol. 3 No. 2 |
137 |
Testosterone 10-mg Troches |
Vol. 3 No. 2 |
138 |
Testosterone 10-mg/0.1-mL Sublingual Drops |
Vol. 3 No. 2 |
139 |
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags |
Vol. 3 No. 2 |
156 |
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography |
Vol. 3 No. 2 |
158 |
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 |
Vol. 3 No. 2 |
160 |
HRT Marketing Tip |
Vol. 3 No. 1 |
37 |
Progesterone 200-mg/mL in Grapeseed-Oil Suspension |
Vol. 2 No. 6 |
442 |
Triple Estrogen 2.5-mg Capsules (Lactose Free) |
Vol. 2 No. 6 |
445 |
Treatment of Skin Aging with Topical Estrogens |
Vol. 2 No. 4 |
270 |
Essential Truths About HRT |
Vol. 2 No. 1 |
10 |
Interview on HRT: Christiane Northrup, MD, FACOG |
Vol. 2 No. 1 |
12 |
HRT and the Continuing Education of Health Care Professionals |
Vol. 2 No. 1 |
18 |
Estrogen and Breast Cancer: Is There a Link? |
Vol. 2 No. 1 |
21 |
Estrogen in the Treatment and Prevention of Alzheimer's Disease |
Vol. 2 No. 1 |
24 |
Reviews: Books on HRT |
Vol. 2 No. 1 |
30 |
Estradiol 1-mg Vaginal Suppositories |
Vol. 2 No. 1 |
48 |
Estradiol Topical Gel |
Vol. 2 No. 1 |
49 |
Estradiol Vaginal Cream (0.2%) |
Vol. 2 No. 1 |
50 |
Estradiol Vaginal Gel (0.2%) |
Vol. 2 No. 1 |
51 |
Methyltestosterone 6-mg/g Gel |
Vol. 2 No. 1 |
52 |
Progesterone Enema 100- and 200-mg/mL |
Vol. 2 No. 1 |
53 |
Progesterone-Estradiol-Testosterone in Oil Capsules |
Vol. 2 No. 1 |
54 |
Progesterone in Oil Capsules |
Vol. 2 No. 1 |
55 |
Progesterone Nasal Spray (2%) |
Vol. 2 No. 1 |
56 |
Progesterone Oral Suspension (40-mg/mL) |
Vol. 2 No. 1 |
57 |
Progesterone 3% Vaginal Gel |
Vol. 2 No. 1 |
58 |
Progesterone Troches (100-mg, Soft) |
Vol. 2 No. 1 |
59 |
Progesterone Troches (300-mg, Hard) |
Vol. 2 No. 1 |
60 |
Progesterone Troches (400-mg, Soft) |
Vol. 2 No. 1 |
61 |
Progesterone 200-mg Buccal Tablets |
Vol. 2 No. 1 |
62 |
Progesterone 200-mg Linguets (Soft) |
Vol. 2 No. 1 |
63 |
Progesterone Vaginal Cream (5%) |
Vol. 2 No. 1 |
64 |
Progesterone Vaginal Suppositories (Fatty Acid Base) |
Vol. 2 No. 1 |
65 |
Progesterone Vaginal Suppositories (Polyethylene Glycol Bases) |
Vol. 2 No. 1 |
66 |
Testosterone Propionate Gel |
Vol. 2 No. 1 |
67 |
Testosterone Propionate 100-mg/6 mL Cream |
Vol. 2 No. 1 |
68 |
Testosterone Propionate 2% Ointment |
Vol. 2 No. 1 |
69 |
Testosterone 0.625-mg Troches |
Vol. 2 No. 1 |
70 |
Estriol Solution for Iontophoresis for Acne Scars |
Vol. 1 No. 6 |
411 |
Assaying Progesterone in Extemporaneously Prepared Suppositories |
Vol. 1 No. 5 |
339 |
The Changing Body |
Vol. 1 No. 3 |
144 |
Progesterone 100-mg in Peanut-Oil Capsules |
Vol. 1 No. 3 |
182 |
Triple Estrogen 2.5-mg in Oil Capsules |
Vol. 1 No. 3 |
185 |
Triple Estrogen 2.5-mg in Lactose Capsules |
Vol. 1 No. 3 |
186 |
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules |
Vol. 1 No. 3 |
187 |
HDDM Hard Troche |
Vol. 1 No. 1 |
29 |
HDDM Soft Troche |
Vol. 1 No. 1 |
30 |
HDDM Sugar Troche |
Vol. 1 No. 1 |
30 |